Fraxinol

CAS No. 486-28-2

Fraxinol( —— )

Catalog No. M19428 CAS No. 486-28-2

Fraxinol is a predicted metabolite generated by BioTransformer1 that is produced by the metabolism of 5 7-dimethoxy-2h-chromen-2-one.

Fraxinol is a predicted metabolite generated by BioTransformer1 that is produced by the metabolism of 5 7-dimethoxy-2h-chromen-2-one.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 119 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Fraxinol
  • Note
    Research use only, not for human use.
  • Brief Description
    Fraxinol is a predicted metabolite generated by BioTransformer1 that is produced by the metabolism of 5 7-dimethoxy-2h-chromen-2-one.
  • Description
    Fraxinol is a predicted metabolite generated by BioTransformer1 that is produced by the metabolism of 5 7-dimethoxy-2h-chromen-2-one. It is generated by cyp1a2 cyp2a6 cyp2b6 cyp2c9 cyp2c19 and cyp2e1 enzymes via an aromatic-hydroxylation-of-fused-benzene-ring-pattern1 reaction.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    486-28-2
  • Formula Weight
    222.2
  • Molecular Formula
    C11H10O5
  • Purity
    >98% (HPLC)
  • Solubility
    Chloroform Dichloromethane Ethyl Acetate Acetone etc.:Soluble;DMSO:Soluble
  • SMILES
    COC1=C(C(=C2C=CC(=O)OC2=C1)OC)O
  • Chemical Name
    2H-1-Benzopyran-2-one 6-hydroxy-57-dimethoxy-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Hammoda H. Ela M. El-Lankany A. El-Hanbali O. Zaki C. & Ghazy N. (2008). New constituents of Artemisia monosperma Del.?Pharmazie.?63(8) 611-4.
molnova catalog
related products
  • BETA-CFT sulfate

    BETA-CFT sulfate is a chemical compound.

  • Sergliflozin etabona...

    Sergliflozin etabonate, a SGLT-2 inhibitor, is used potentially for the treatment of type 2 diabetes and obesity.

  • MCI-225

    MCI-225 is a selective inhibitor of NA reuptake with 5-HT3 receptor antagonism.MCI-225 (10 mg/kg, po) showed comparable anxiolytic-like effect between single and 5-day repeated administration.?